The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study

Aims  Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high‐risk population with clinically manifest vascular disease is unknown. The objectives of this study were to examine the impact of Type 2 diabetes and microalbuminuria on future CVD events.

[1]  C. Stehouwer,et al.  Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. , 2006, Journal of the American Society of Nephrology : JASN.

[2]  C. Meisinger,et al.  Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. , 2006, European heart journal.

[3]  N. Wareham,et al.  What is the evidence that microalbuminuria is a predictor of cardiovascular disease events? , 2005, Current opinion in nephrology and hypertension.

[4]  L. Bouter,et al.  Microalbuminuria is associated with impaired brachial artery, flow-mediated vasodilation in elderly individuals without and with diabetes: further evidence for a link between microalbuminuria and endothelial dysfunction--the Hoorn Study. , 2004, Kidney international. Supplement.

[5]  K. Borch-Johnsen,et al.  Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .

[6]  Deeb N Salem,et al.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. , 2004, Journal of the American Society of Nephrology : JASN.

[7]  N. Day,et al.  Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. , 2004, International journal of epidemiology.

[8]  L. Bouter,et al.  Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. , 2003, European heart journal.

[9]  J. Coresh,et al.  Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. , 2003, Kidney international.

[10]  E. Rimm,et al.  The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. , 2002, Journal of the American College of Cardiology.

[11]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[12]  W C Willett,et al.  The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. , 2001, Archives of internal medicine.

[13]  J. Manson,et al.  Diabetes and all-cause and coronary heart disease mortality among US male physicians. , 2001, Archives of internal medicine.

[14]  R. Klein,et al.  The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. , 2000, Archives of internal medicine.

[15]  A. Algra,et al.  Second Manifestations of ARTerial disease (SMART) study: Rationale and design , 1999, European Journal of Epidemiology.

[16]  M. Schroll,et al.  Urinary albumin excretion. An independent predictor of ischemic heart disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Sowers,et al.  Diabetes and cardiovascular disease. , 1999, Diabetes care.

[18]  A. Fitzgerald,et al.  Microalbuminuria and coronary heart disease in NIDDM: an incidence study. , 1998, Diabetes.

[19]  B. Howard,et al.  Adverse Effects of Diabetes on Multiple Cardiovascular Disease Risk Factors in Women: The Strong Heart Study , 1998, Diabetes Care.

[20]  B. Fagerberg,et al.  Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. , 1997, The American journal of cardiology.

[21]  H. Gerstein,et al.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. , 1997, Archives of internal medicine.

[22]  C. Schalkwijk,et al.  [Vascular complications in diabetes mellitus: role of endothelial dysfunction]. , 1996, Nederlands tijdschrift voor geneeskunde.

[23]  M. Stern.  Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis , 1995, Diabetes.

[24]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[25]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .

[26]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[27]  M. Laakso,et al.  Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women , 2005, Diabetologia.

[28]  J. Manson,et al.  The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women , 2001 .

[29]  C. Stehouwer,et al.  Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure , 1998, Diabetologia.